Sponsored Reports
| Previous Close (in USD) | 13.49 |
|---|---|
| Change | -0.130 0.964% |
| 52 W H/L (in USD) | 48.250/16.720 |
| EBITDA (in USD) | 173.355M |
| PE Ratio | 8.76 |
| Volume | 618659 |
| Diluted Eps TTM | 2.24 |
| Total Assets (in USD) | 863.286M |
|---|---|
| Total Liabilities (in USD) | 75.914M |
| Revenue TTM (in USD) | 466.258M |
| Cash (in USD) | 144.411M |
| Market Cap (in USD) | 1,660.227 M |
| Revenue Per Share TTM | 5.559 |
| Gross Profit TTM (in USD) | 380.786M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
InMode Ltd
Employees: 581
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Yair Malca | Chief Financial Officer | 1978 |
| 2. | Mr. Alon Yaari | VP of Operations | NA |
| 3. | Ms. Nava Tal-Launer | Chief Information Officer | NA |
| 4. | Mr. Shakil Lakhani | Pres of North America | 1983 |
| 5. | Dr. Spero Theodorou M.D. | Chief Medical Officer | 1972 |
| 6. | Mr. Moshe Mizrahy | Chairman & CEO | 1953 |
| 7. | Dr. Michael Kreindel | CTO & Director | 1968 |
| 8. | Mr. Shakil Lakhani | President of North America | 1983 |
| 9. | Mr. Alon Yaari | Vice President of Operations | NA |
Peers
Sector: Healthcare
Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ABT
Abbott Laboratories |
-2.120 2.339% | 90.36 | 25.970 | 17.241 | 3.570 | 3.200 | 3.805 | 16.753 |
|
SYK
Stryker Corporation |
-9.440 3.040% | 308 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
|
MDT
Medtronic PLC |
-3.180 3.911% | 81 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
|
BSX
Boston Scientific Corp |
-1.970 4.199% | 46.6 | 31.490 | 17.241 | 4.407 | 3.650 | 4.878 | 19.194 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | 201.466M | 168.002M | 76.132M | 62.041M | 23.625M |
| Minority Interest | 0M | -0.103M | 1.512M | 3.737M | 3.6M |
| Net Income | 161.52M | 164.971M | 75.03M | 61.145M | 22.371M |
| Selling General Administrative | 9.931M | 8.411M | 6.418M | 3.958M | 4.814M |
| Gross Profit | 380.786M | 303.973M | 175.258M | 136.123M | 85.105M |
| Reconciled Depreciation | 0.68M | 0.517M | 0.416M | 0.302M | 0.184M |
| Ebit | 197.854M | 167.477M | 72.841M | 59.618M | 39.489M |
| Ebitda | 198.534M | 167.994M | 73.257M | 59.92M | 39.673M |
| Depreciation And Amortization | 0.68M | 0.517M | 0.416M | 0.302M | 0.184M |
| Operating Income | 197.854M | 167.477M | 72.841M | 59.618M | 23.489M |
| Other Operating Expenses | 256.417M | 190.088M | 133.266M | 96.743M | 68.673M |
| Interest Expense | 3.612M | 0.422M | 3.296M | 2.41M | 0.136M |
| Tax Provision | 39.946M | 2.928M | 1.107M | 0.883M | 1.26M |
| Interest Income | 3.612M | 0.525M | 3.291M | 2.423M | 0.136M |
| Net Interest Income | 3.612M | 0.525M | 3.291M | 2.423M | 0.136M |
| Income Tax Expense | 39.946M | 2.928M | 1.107M | 0.883M | 1.26M |
| Total Revenue | 454.271M | 357.565M | 206.107M | 156.361M | 100.162M |
| Total Operating Expenses | 182.932M | 136.496M | 102.417M | 76.505M | 53.616M |
| Cost Of Revenue | 73.485M | 53.592M | 30.849M | 20.238M | 15.057M |
| Total Other Income Expense Net | 3.612M | 0.525M | 3.291M | 2.423M | -8M |
| Net Income From Continuing Ops | 161.52M | 165.074M | 75.025M | 61.158M | 22.365M |
| Net Income Applicable To Common Shares | 161.52M | 164.971M | 75.03M | 61.015M | 21.836M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 863.286M | 644.409M | 478.541M | 295.761M | 218.385M |
| Intangible Assets | - | - | - | - | - |
| Other Current Assets | 15.001M | 13.826M | 8.404M | 1.639M | - |
| Total Liab | 75.914M | 89.791M | 62.739M | 40.286M | 38.582M |
| Total Stockholder Equity | 787.372M | 554.618M | 415.802M | 255.475M | 179.803M |
| Other Current Liab | 36.843M | 50.527M | 28.057M | 16.72M | 13.205M |
| Common Stock | 0.245M | 0.241M | 0.239M | 0.108M | 0.093M |
| Capital Stock | 0.245M | 0.241M | 0.239M | 0.108M | 0.093M |
| Retained Earnings | 693.426M | 495.507M | 333.987M | 169.016M | 93.986M |
| Good Will | - | - | - | - | - |
| Other Assets | - | 7.067M | 2.102M | 3.435M | 2.273M |
| Cash | 144.411M | 97.54M | 68.136M | 68.938M | 44.727M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 64.136M | 82.02M | 51.85M | 35.03M | 32.494M |
| Current Deferred Revenue | 10.923M | 13.798M | 13.805M | 11.9M | 15.587M |
| Net Debt | -135.394M | -92.578M | -64.829M | -68.58M | -43.983M |
| Short Term Debt | 2.404M | 1.453M | 1.209M | - | - |
| Short Long Term Debt | - | - | - | - | - |
| Short Long Term Debt Total | 9.017M | 4.962M | 3.307M | 0.358M | 0.744M |
| Other Stockholder Equity | 95.38M | 66.363M | 82.895M | 85.995M | 85.6M |
| Property Plant Equipment | - | 7.371M | 5.725M | 2.135M | 2.304M |
| Total Current Assets | 845.33M | 629.371M | 470.114M | 289.591M | 213.208M |
| Long Term Investments | 0.7M | 0.6M | 0.6M | 0.6M | 0.6M |
| Short Term Investments | 597.194M | 449.843M | 347.778M | 191.596M | 148.635M |
| Net Receivables | 43.629M | 42.091M | 33.174M | 14.074M | 10.438M |
| Long Term Debt | - | - | - | - | - |
| Inventory | 45.095M | 39.897M | 21.026M | 14.983M | 9.408M |
| Accounts Payable | 13.966M | 16.242M | 8.779M | 6.41M | 3.702M |
| Accumulated Other Comprehensive Income | -1.679M | -7.493M | -1.319M | 0.356M | 0.124M |
| Non Currrent Assets Other | 3.67M | 3.973M | 0.768M | 3.371M | 0.374M |
| Non Current Assets Total | 17.956M | 15.038M | 8.427M | 6.17M | 5.177M |
| Capital Lease Obligations | 9.017M | 4.962M | 4.516M | 0.358M | 0.744M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | -109.474M | -159.167M | -42.842M | -112.452M | -29.739M |
| Total Cashflows From Investing Activities | -109.474M | -160.106M | -43.305M | -112.452M | -29.739M |
| Total Cash From Financing Activities | -41.085M | -15.022M | -12.442M | 70.173M | 0.186M |
| Net Income | 161.52M | 165.074M | 75.025M | 61.158M | 22.365M |
| Change In Cash | 29.404M | -0.802M | 24.211M | 20.006M | 7.128M |
| Begin Period Cash Flow | 68.136M | 68.938M | 44.727M | 24.721M | 17.593M |
| End Period Cash Flow | 97.54M | 68.136M | 68.938M | 44.727M | 24.721M |
| Total Cash From Operating Activities | 181.578M | 174.885M | 79.225M | 62.206M | 36.886M |
| Depreciation | 0.68M | 0.517M | 0.416M | 0.302M | 0.184M |
| Other Cashflows From Investing Activities | - | - | - | -111.759M | -29.358M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | -18.871M | -6.043M | -5.575M | -2.445M | -1.891M |
| Sale Purchase Of Stock | -42.637M | -35.365M | -17.218M | 70.173M | 0.186M |
| Other Cashflows From Financing Activities | 1.552M | 20.343M | 4.776M | 0.389M | 0.186M |
| Capital Expenditures | 1.575M | 0.939M | 0.463M | 0.693M | 0.381M |
| Change In Working Capital | -4.468M | -3.812M | -10.612M | 0.537M | 4.79M |
| Other Non Cash Items | -0.69M | 1.914M | -0.178M | -0.754M | 8.192M |
| Free Cash Flow | 180.003M | 173.946M | 78.762M | 61.513M | 36.505M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | iShares Russell 2000 ETF | 2 years ago | 1800450 |
| 2. | JHancock Small Cap Core NAV | 2 years ago | 990495 |
| 3. | Swedbank Robur Small Cap Global A | 2 years ago | 816000 |
| 4. | Fidelity Small Cap Index | 2 years ago | 791964 |
| 5. | Delaware Ivy Small Cap Growth C | 2 years ago | 778483 |
| 6. | iShares Russell 2000 Growth ETF | 2 years ago | 657473 |
| 7. | Boston Trust Walden Small Cap | 2 years ago | 586767 |
| 8. | North Growth US Equity | 2 years ago | 549370 |
| 9. | LO Funds Golden Age SH EUR PA | 2 years ago | 503432 |
| 10. | iShares Core MSCI EAFE ETF | 2 years ago | 482919 |
| 11. | State St Russell Sm/Mid Cp® Indx NL Cl C | 2 years ago | 467000 |
| 12. | CREF Stock R1 | 2 years ago | 422512 |
| 13. | Vanguard Russell 2000 ETF | 2 years ago | 291807 |
| 14. | State St Russell Sm Cap® Indx SL Cl I | 2 years ago | 280800 |
| 15. | iShares MSCI EAFE Small-Cap ETF | 2 years ago | 277057 |
| 16. | Acadian Non-US Small-Cap Developed Eqty | 2 years ago | 270181 |
| 17. | Nordea 2 - Global Enhanced Sm Cap BI USD | 2 years ago | 238887 |
| 18. | NT R2000 Growth Index Fund - NL | 2 years ago | 232299 |
| 19. | MUAM World Beauty Mother | 2 years ago | 228462 |
| 20. | NT R2000 Index Fund - NL | 2 years ago | 215502 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | BTIM Corp | 2 years ago | 1447196 |
| 2. | BlackRock Inc | 2 years ago | 6587699 |
| 3. | Meitav Dash Investments Ltd | 2 years ago | 1940890 |
| 4. | Renaissance Technologies Corp | 2 years ago | 1938896 |
| 5. | LSV Asset Management | 2 years ago | 1879771 |
| 6. | State Street Corporation | 2 years ago | 1835930 |
| 7. | MENORA MIVTACHIM HOLDINGS LIMITED | 2 years ago | 1174435 |
| 8. | Morgan Stanley - Brokerage Accounts | 2 years ago | 1094300 |
| 9. | DDD Partners, LLC | 2 years ago | 1060731 |
| 10. | Nuveen Asset Management, LLC | 2 years ago | 966079 |
| 11. | Geode Capital Management, LLC | 2 years ago | 962448 |
| 12. | Harel Insurance Invests & Fin Srvcs Ltd | 2 years ago | 900831 |
| 13. | Migdal Insurance & Financial Holdings Ltd | 2 years ago | 849166 |
| 14. | Disciplined Growth Investors Inc | 2 years ago | 782531 |
| 15. | Vanguard Group Inc | 2 years ago | 751537 |
| 16. | UBS Group AG | 2 years ago | 742300 |
| 17. | Acadian Asset Management LLC | 2 years ago | 687765 |
| 18. | Boston Partners Global Investors, Inc | 2 years ago | 664672 |
| 19. | Goldman Sachs Group Inc | 2 years ago | 632918 |
| 20. | Clal Insurance Enterprises Holdings Ltd | 2 years ago | 603288 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).